358 related articles for article (PubMed ID: 6424713)
21. Intracellular translocation of fluorescent sphingolipids in cultured fibroblasts: endogenously synthesized sphingomyelin and glucocerebroside analogues pass through the Golgi apparatus en route to the plasma membrane.
Lipsky NG; Pagano RE
J Cell Biol; 1985 Jan; 100(1):27-34. PubMed ID: 3965473
[TBL] [Abstract][Full Text] [Related]
22. In situ assay of acid sphingomyelinase and ceramidase based on LDL-mediated lysosomal targeting of ceramide-labeled sphingomyelin.
Levade T; Leruth M; Graber D; Moisand A; Vermeersch S; Salvayre R; Courtoy PJ
J Lipid Res; 1996 Dec; 37(12):2525-38. PubMed ID: 9017505
[TBL] [Abstract][Full Text] [Related]
23. Niemann-Pick type II fibroblasts exhibit impaired cholesterol esterification in response to sphingomyelin hydrolysis.
Byers DM; Morgan MW; Cook HW; Palmer FB; Spence MW
Biochim Biophys Acta; 1992 Jan; 1138(1):20-6. PubMed ID: 1737066
[TBL] [Abstract][Full Text] [Related]
24. Depletion of plasma-membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts.
Slotte JP; Bierman EL
Biochem J; 1988 Mar; 250(3):653-8. PubMed ID: 3390137
[TBL] [Abstract][Full Text] [Related]
25. Cholesterol-dependent increases in glucosylceramide synthase activity in Niemann-Pick disease type C model cells: Abnormal trafficking of endogenously formed ceramide metabolites by inhibition of the enzyme.
Hashimoto N; Matsumoto I; Takahashi H; Ashikawa H; Nakamura H; Murayama T
Neuropharmacology; 2016 Nov; 110(Pt A):458-469. PubMed ID: 27539961
[TBL] [Abstract][Full Text] [Related]
26. Exocytosis of acid sphingomyelinase by wounded cells promotes endocytosis and plasma membrane repair.
Tam C; Idone V; Devlin C; Fernandes MC; Flannery A; He X; Schuchman E; Tabas I; Andrews NW
J Cell Biol; 2010 Jun; 189(6):1027-38. PubMed ID: 20530211
[TBL] [Abstract][Full Text] [Related]
27. Evidence for both endogenous and exogenous sources of the sphingomyelin storage in lymphoid cell lines from patients with Niemann-Pick disease types A and B.
Levade T; Salvayre R; Maret A; Douste-Blazy L
J Inherit Metab Dis; 1988; 11(2):151-7. PubMed ID: 3139926
[TBL] [Abstract][Full Text] [Related]
28. Toward gene therapy for Niemann-Pick disease (NPD): separation of retrovirally corrected and noncorrected NPD fibroblasts using a novel fluorescent sphingomyelin.
Dinur T; Schuchman EH; Fibach E; Dagan A; Suchi M; Desnick RJ; Gatt S
Hum Gene Ther; 1992 Dec; 3(6):633-9. PubMed ID: 1482703
[TBL] [Abstract][Full Text] [Related]
29. Permeability barrier disorder in Niemann-Pick disease: sphingomyelin-ceramide processing required for normal barrier homeostasis.
Schmuth M; Man MQ; Weber F; Gao W; Feingold KR; Fritsch P; Elias PM; Holleran WM
J Invest Dermatol; 2000 Sep; 115(3):459-66. PubMed ID: 10951284
[TBL] [Abstract][Full Text] [Related]
30. An enzymatic assay for quantifying sphingomyelin in tissues and plasma from humans and mice with Niemann-Pick disease.
He X; Chen F; Gatt S; Schuchman EH
Anal Biochem; 2001 Jun; 293(2):204-11. PubMed ID: 11399033
[TBL] [Abstract][Full Text] [Related]
31. Modifications of sphingomyelin and phosphatidylcholine metabolism by tricyclic antidepressants and phenothiazines.
Albouz S; Le Saux F; Wenger D; Hauw JJ; Baumann N
Life Sci; 1986 Jan; 38(4):357-63. PubMed ID: 3945166
[TBL] [Abstract][Full Text] [Related]
32. Fluorescent, short-chain C6-NBD-sphingomyelin, but not C6-NBD-glucosylceramide, is subject to extensive degradation in the plasma membrane: implications for signal transduction related to cell differentiation.
Kok JW; Babia T; Klappe K; Hoekstra D
Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):905-12. PubMed ID: 7639709
[TBL] [Abstract][Full Text] [Related]
33. Biosynthesis of phosphatidylcholine from a phosphocholine precursor pool derived from the late endosomal/lysosomal degradation of sphingomyelin.
Jansen SM; Groener JE; Bax W; Suter A; Saftig P; Somerharju P; Poorthuis BJ
J Biol Chem; 2001 Jun; 276(22):18722-7. PubMed ID: 11376003
[TBL] [Abstract][Full Text] [Related]
34. Golgi staining by two fluorescent ceramide analogues in cultured fibroblasts requires metabolism.
Pütz U; Schwarzmann G
Eur J Cell Biol; 1995 Oct; 68(2):113-21. PubMed ID: 8575458
[TBL] [Abstract][Full Text] [Related]
35. Natural ceramide is unable to escape the lysosome, in contrast to a fluorescent analogue.
Chatelut M; Leruth M; Harzer K; Dagan A; Marchesini S; Gatt S; Salvayre R; Courtoy P; Levade T
FEBS Lett; 1998 Apr; 426(1):102-6. PubMed ID: 9598987
[TBL] [Abstract][Full Text] [Related]
36. Abnormalities of lysosomes in human diploid fibroblasts from patients with Farber's disease.
Chen WW; Decker GL
Biochim Biophys Acta; 1982 Oct; 718(2):185-92. PubMed ID: 6814495
[TBL] [Abstract][Full Text] [Related]
37. Lipid recycling between the plasma membrane and intracellular compartments: transport and metabolism of fluorescent sphingomyelin analogues in cultured fibroblasts.
Koval M; Pagano RE
J Cell Biol; 1989 Jun; 108(6):2169-81. PubMed ID: 2738091
[TBL] [Abstract][Full Text] [Related]
38. Sphingolipid metabolism in cultured fibroblasts: microscopic and biochemical studies employing a fluorescent ceramide analogue.
Lipsky NG; Pagano RE
Proc Natl Acad Sci U S A; 1983 May; 80(9):2608-12. PubMed ID: 6573674
[TBL] [Abstract][Full Text] [Related]
39. Studies on the activation of sphingomyelinase activity in Niemann-Pick type A, B, and C fibroblasts: enzymological differentiation of types A and B.
Poulos A; Ranieri E; Shankaran P; Callahan JW
Pediatr Res; 1984 Nov; 18(11):1088-93. PubMed ID: 6096798
[TBL] [Abstract][Full Text] [Related]
40. Biochemical studies in Niemann-Pick disease. III. In vitro and in vivo assays of sphingomyelin degradation in cultured skin fibroblasts and amniotic fluid cells for the diagnosis of the various forms of the disease.
Vanier MT; Rousson R; Garcia I; Bailloud G; Juge MC; Revol A; Louisot P
Clin Genet; 1985 Jan; 27(1):20-32. PubMed ID: 3978837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
